1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE
1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE structure
|
Common Name | 1,3-DIPROPYL-8-P-SULFOPHENYLXANTHINE | ||
|---|---|---|---|---|
| CAS Number | 89073-57-4 | Molecular Weight | 392.43000 | |
| Density | 1.405g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C17H20N4O5S | Melting Point | >300ºC | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Name | 4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)benzenesulfonic acid |
|---|---|
| Synonym | More Synonyms |
| Density | 1.405g/cm3 |
|---|---|
| Melting Point | >300ºC |
| Molecular Formula | C17H20N4O5S |
| Molecular Weight | 392.43000 |
| Exact Mass | 392.11500 |
| PSA | 135.43000 |
| LogP | 2.70080 |
| Index of Refraction | 1.607 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933990090 |
|
~%
1,3-DIPROPYL-8-... CAS#:89073-57-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-DIPROPYL-8-... CAS#:89073-57-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-DIPROPYL-8-... CAS#:89073-57-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
|
~%
1,3-DIPROPYL-8-... CAS#:89073-57-4 |
| Literature: Journal of Medicinal Chemistry, , vol. 28, # 4 p. 487 - 492 |
![N-[3-(dimethylamino)propyl]-4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)benzenesulfonamide structure](https://image.chemsrc.com/caspic/139/96445-35-1.png)
CAS#:96445-35-1| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
Am. J. Physiol. Renal Physiol. 304(1) , F49-55, (2013) In a previous study, we demonstrated that human proximal tubular epithelial cells obtained from a commercial source metabolized extracellular 2',3'-cAMP to 2'-AMP and 3'-AMP and extracellular 2'-AMP a... |
|
|
Expression of the 2',3'-cAMP-adenosine pathway in astrocytes and microglia.
J. Neurochem. 118 , 979-987, (2011) Many organs express the extracellular 3',5'-cAMP-adenosine pathway (conversion of extracellular 3',5'-cAMP to 5'-AMP and 5'-AMP to adenosine). Some organs release 2',3'-cAMP (isomer of 3',5'-cAMP) and... |
|
|
Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: possible role of the neutrophil chemoattractant response.
J. Pharmacol. Exp. Ther. 292(3) , 929-38, (2000) Recent studies have demonstrated that three membrane-permeant A(1) receptor antagonists reduced infarct size in a model of ischemia followed by brief reperfusion. However, it was not determined whethe... |
| 1,3-Dspx |
| 4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-benzenesulfonic acid |
| Benzenesulfonic acid,4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl) |
| DPSPX |
| PSPX |
| 1,3-Dipropyl-8-(p-sulfophenyl)xanthine |
| 4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)benzenesulfonic acid |
| MFCD00055080 |